Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,140 | -6,460 | -21,180 | -14,250 | -8,120 |
| Depreciation Amortization | 460 | 230 | 710 | 650 | 450 |
| Other Working Capital | 2,380 | -380 | 450 | 1,190 | -690 |
| Other Operating Activity | 0 | 0 | 10 | 20 | 0 |
| Operating Cash Flow | $-12,300 | $-6,610 | $-20,010 | $-12,390 | $-8,360 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -440 | -280 | -630 | -350 | -310 |
| Other Investing Activity | -26,090 | -15,150 | 21,210 | 16,010 | 13,690 |
| Investing Cash Flow | $-26,530 | $-15,430 | $20,580 | $15,660 | $13,380 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 40,550 | 33,080 | 440 | -210 | 220 |
| Financing Cash Flow | $40,550 | $33,080 | $440 | $-210 | $220 |
| Beginning Cash Position | 4,510 | 4,600 | 3,490 | 3,480 | 3,510 |
| End Cash Position | 6,230 | 15,640 | 4,500 | 6,530 | 8,760 |
| Net Cash Flow | $1,720 | $11,030 | $1,010 | $3,050 | $5,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,300 | -6,610 | -20,010 | -12,390 | -8,360 |
| Free Cash Flow | -12,300 | -6,610 | -20,010 | -12,390 | -8,360 |